Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic promise of engineered nonsense suppressor tRNAs
Joseph J. Porter, Christina S. Heil, John D. Lueck
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

tRNA dysregulation and disease
Esteban A. Orellana, Elisabeth Siegal, Richard I. Gregory
Nature Reviews Genetics (2022) Vol. 23, Iss. 11, pp. 651-664
Closed Access | Times Cited: 113
AAV-delivered suppressor tRNA overcomes a nonsense mutation in mice
Jiaming Wang, Yue Zhang, Craig A. Mendonca, et al.
Nature (2022) Vol. 604, Iss. 7905, pp. 343-348
Open Access | Times Cited: 87
Engineered tRNAs suppress nonsense mutations in cells and in vivo
Suki Albers, Elizabeth Cheresh Allen, Nikhil Bharti, et al.
Nature (2023) Vol. 618, Iss. 7966, pp. 842-848
Open Access | Times Cited: 68
RNA‐based medicine: from molecular mechanisms to therapy
Anke Sparmann, Jörg Vogel
The EMBO Journal (2023) Vol. 42, Iss. 21
Open Access | Times Cited: 58
Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes
Hironori Adachi, Yi Pan, Xueyang He, et al.
Molecular Cell (2023) Vol. 83, Iss. 4, pp. 637-651.e9
Open Access | Times Cited: 44
Selective gene expression maintains human tRNA anticodon pools during differentiation
Lexi Gao, Andrew Behrens, Geraldine Rodschinka, et al.
Nature Cell Biology (2024) Vol. 26, Iss. 1, pp. 100-112
Open Access | Times Cited: 28
Transfer RNA modifications and cellular thermotolerance
Takayuki Ohira, Tsutomu Suzuki
Molecular Cell (2024) Vol. 84, Iss. 1, pp. 94-106
Open Access | Times Cited: 23
Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs
Wooree Ko, Joseph J. Porter, Matthew T. Sipple, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 28, pp. 685-701
Open Access | Times Cited: 50
The diverse structural modes of tRNA binding and recognition
Anna Biela, Alexander Hammermeister, Igor Kaczmarczyk, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 8, pp. 104966-104966
Open Access | Times Cited: 34
Stimuli‐Responsive Nanotechnology for RNA Delivery
Hui Zhou, Dean Shuailin Chen, Caleb J. Hu, et al.
Advanced Science (2023) Vol. 10, Iss. 36
Open Access | Times Cited: 25
Near-cognate tRNAs increase the efficiency and precision of pseudouridine-mediated readthrough of premature termination codons
Nan Luo, Qiang Huang, Liting Dong, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 8
Repurposing tRNAs for nonsense suppression
Suki Albers, Bertrand Beckert, Marco C. Matthies, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Therapeutic Approaches for Patients with Cystic Fibrosis Not Eligible for Current CFTR Modulators
Isabelle Fajac, Isabelle Sermet‐Gaudelus
Cells (2021) Vol. 10, Iss. 10, pp. 2793-2793
Open Access | Times Cited: 37
Mammalian proteome expansion by stop codon readthrough
Lekha E. Manjunath, Anumeha Singh, Saubhik Som, et al.
Wiley Interdisciplinary Reviews - RNA (2022) Vol. 14, Iss. 2
Closed Access | Times Cited: 28
Approaches to Gene Modulation Therapy for ALS
Katharina E. Meijboom, Robert H. Brown
Neurotherapeutics (2022) Vol. 19, Iss. 4, pp. 1159-1179
Open Access | Times Cited: 24
Late-Stage Functionalization of Living Organisms: Rethinking Selectivity in Biology
Andrew M. Giltrap, Yizhi Yuan, Benjamin G. Davis
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 889-928
Open Access | Times Cited: 5
Function and Therapeutic Implications of tRNA Derived Small RNAs
Briana Wilson, Anindya Dutta
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 20
Gene, RNA, and ASO-based therapeutic approaches in Cystic Fibrosis
Norm Allaire, Uta Griesenbach, Batsheva Kerem, et al.
Journal of Cystic Fibrosis (2023) Vol. 22, pp. S39-S44
Open Access | Times Cited: 13
Running a genetic stop sign accelerates oxygen metabolism and energy production in horses
Gianni M. Castiglione, Xin Chen, Zhenhua Xu, et al.
Science (2025) Vol. 387, Iss. 6741
Closed Access
Mechanism-based approach in designing patient-specific combination therapies for nonsense mutation diseases
Saleem Y. Bhat, A.A. Bhattacharya, Hong Li, et al.
Nucleic Acids Research (2025) Vol. 53, Iss. 6
Open Access
RNA in the Central Dogma: tRNAs
Phei Er Saw, Erwei Song
(2025), pp. 71-95
Closed Access
Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches
Pedro Morais, R. Zhang, Yi‐Tao Yu
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1284-1284
Open Access | Times Cited: 3
Tuning tRNAs for improved translation
Joshua L. Weiss, J. C. Decker, Ariadna Bolano, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access | Times Cited: 3
Novel technologies are turning a dream into reality: conditionally replicating viruses as vaccines
Yan‐Dong Tang, Changqing Yu, Xuehui Cai
Trends in Microbiology (2023) Vol. 32, Iss. 3, pp. 292-301
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top